3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Sarcoma, Synovial
9
Sarcoma
9
Osteosarcoma
8
Neoplasms
7
Melanoma
7
Liposarcoma, Myxoid
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Dendritic Cell Sarcoma, Interdigitating
6
Sarcoma, Ewing
5
Ovarian Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Rhabdomyosarcoma
4
Lymphoma, Follicular
4
Leukemia, Prolymphocytic
4
Triple Negative Breast Neoplasms
3
Lymphoma, T-Cell
3
Leukemia
3
Esophageal Neoplasms
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
fludarabine
×
Sarcoma
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled